Panacea Biotec Ltd (NSE:PANACEABIO) Share Price

Company Profile

Business description
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.
Contact
Mathura Road, B-1 Extension/G-3
Mohan Co-operative Industrial Estate
New Delhi110 044
IND
T: +91 1141679000
https://www.panaceabiotec.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
1,302

Recommended

Simplification plan complete, organic growth now the focus.

Nathan Zaia | 20 August 2025

Cost containment and growing revenue bode well for profit margins.

Adrian Atkins | 20 August 2025

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Shane Ponraj, CFA | 19 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,284.20	51.60	0.56%
CAC 40	7,927.61	45.42	-0.57%
DAX 40	24,223.76	53.21	-0.22%
Dow JONES (US)	44,938.31	16.04	0.04%
FTSE 100	9,271.84	16.30	-0.18%
HKSE	25,104.61	61.33	-0.24%
NASDAQ	21,172.86	142.09	-0.67%
Nikkei 225	42,610.17	278.38	-0.65%
NZX 50 Index	13,194.07	122.77	0.94%
S&P 500	6,395.78	15.59	-0.24%
S&P/ASX 200	9,019.10	45.40	0.51%
SSE Composite Index	3,771.10	4.89	0.13%